Medical Devices Startups

Gyala Therapeutics develops autologous immunotherapy based on CAR-T technology targeting CD84 for cancer treatment. The company is a technology-based enterprise supported by Spanish government research and innovation programs.

1 investor

Gylden Pharma develops proprietary dermal delivery platforms for therapeutic medicines, using titanium microneedles and programmable gold nanoparticles to enable rapid, precise drug delivery through the skin. The company focuses on oncology and infectious disease applications including tumor immunotherapy and vaccine development.

1 investor

Bridge Innovations works across the medical device business, including product development, manufacturing, intellectual property, regulatory, reimbursement, and commercialization. It draws on a network of advisors, key opinion leaders, product development and manufacturing partners, and industry connections.

1 investor

Gyre Therapeutics is a biopharmaceutical company developing small-molecule therapeutics for organ fibrosis and inflammatory diseases, with its lead program F351 in clinical evaluation for liver fibrosis in the US and China. The company also operates Cullgen Inc., a subsidiary focused on targeted protein degrader therapies for cancer and inflammatory conditions.

1 investor

Gyros Protein Technologies develops the Gyrolab platform, an immunoassay solution for bioprocess applications in the biotechnology industry. The platform enables automated protein analysis and characterization for biopharmaceutical development and manufacturing.

1 investor

Hackensack Meridian Health is New Jersey's largest health network operating 18 hospitals and over 500 patient care locations, delivering clinical care, medical research, and physician education to improve health outcomes. The organization serves communities across New Jersey with a team of over 41,000 healthcare professionals including nurses, employed physicians, and affiliated physicians.

1 investor

HairDAO is a decentralized research network enabling patients and researchers to collaboratively fund and develop new hair loss treatments through community voting and blockchain-based governance.

1 investor

Hairstetics is a medical device company developing synthetic hair implants for treating hair loss, particularly in women. The procedure involves injecting personalized synthetic hair grafts under local anesthesia, with results visible immediately and minimal recovery time.

1 investor

Hakeem Health operates a telepharmacy platform licensed in the UAE that combines clinical decision support software and pharmacy services. The company serves healthcare professionals and patients with evidence-based diagnostic insights and remote pharmacy care.

1 investor

Hale Animal Health develops novel veterinary pharmaceuticals for companion animals, focused on treatments intended to be effective and safe with fewer side effects. The company targets the pet health market.

1 investor

HALO Precision Diagnostics is a precision medicine and diagnostic services company offering advanced imaging and focal therapy for cancer diagnosis and early treatment. The company serves patients and healthcare providers through centers of excellence staffed by board-certified radiologists and specialists.

1 investor

Hanger, Inc. provides orthotic and prosthetic (O&P) care services and products through clinical locations and device distribution, serving patients with amputations, limb differences, and musculoskeletal disorders. The company operates two segments: Patient Care through over 925 clinic locations nationwide, and Products & Services providing devices, components, and rehabilitative solutions to the broader O&P community and skilled nursing facilities.

1 investor

Bệnh viện Việt Pháp Hà Nội is an international hospital providing European-standard healthcare services including surgical specialties such as cardiac and hepatic transplantation. The hospital serves patients in northern Vietnam and has been operating since 1997 with over 60 doctors and international medical experts.

1 investor

Hansel Medical develops software and hardware for surgical asset tracking in healthcare, using custom beacons and tracking technology to help hospitals and surgery centers manage expensive surgical instruments and equipment. The platform addresses inventory and logistics challenges specific to the healthcare and orthopaedic surgery industries.

1 investor

HAPPE Spine develops spinal fusion technologies, including the INTEGRATE®-C Interbody Fusion System, designed to improve clinical outcomes in orthopedic surgery. The company serves surgeons and orthopedic practices in the spine surgery market.

1 investor

Happitech develops smartphone-based cardiac monitoring technology using photoplethysmography and AI to screen and monitor atrial fibrillation and other arrhythmias, targeting patients requiring remote heart disease surveillance at lower cost than traditional monitoring devices.

1 investor

HapticHeart Solutions builds a device-agnostic system that converts biophysical and physiological signals from cardiac catheterization, electrophysiology, and robotic interventions into haptic feedback delivered to operators through a wearable interface and handle. It targets clinical operators performing catheter-based structural heart and cardiac electrophysiology procedures, aiming to simulate direct tactile sensing such as intracardiac pressure and catheter-tissue contact force.

1 investor

Harbor provides electronic data capture (EDC) software for clinical trial teams, designed to reduce data entry time and enable remote monitoring to improve data quality and accelerate trial timelines.

1 investor

Harbor MedTech develops collagen-based medical devices and bioimplants for surgical wound healing and tissue regeneration. The company's BriDGE technology platform produces products for orthopedic, general surgical, and chronic wound care applications.

1 investor

Harmonic Bionics develops Harmony SHR, a robotic system for upper extremity rehabilitation used to treat patients recovering movement, and partners with distributors outside the US. The company operates in the medical robotics and rehabilitation technology field.

1 investor

Harp Diagnostics is developing Harp 360, a remote patient monitoring platform for inflammatory bowel disease (Crohn's disease and ulcerative colitis) and other GI conditions, combining a home sample collector with an automated cloud-connected testing system. The platform serves IBD patients and their treating physicians as a decision-support and disease-management tool aimed at achieving prolonged remission.

1 investor

Genesis Molecular uses deep learning and molecular simulation to accelerate drug discovery and development. The platform helps identify and optimize drug candidates for challenging diseases.

1 investor

HARTLON manufactures a drug-eluting resorbable vascular stent that provides temporary radial support to arteries during disease treatment and dissolves after healing is complete, leaving the artery in its natural state.

1 investor

Harton Therapeutics offers a GMP-ready platform for advanced 3D cell manufacturing, using a perfusion-based single-use cartridge system with automated process control to produce human cells at scale. It serves researchers, biotech and pharma teams, and manufacturing partners working on immune cell therapies, HSPCs, engineered cells, and stem-derived cells and tissues.

1 investor